Estimation of the costs of informal care associated with high-prevalence neurological diseases in Spain;Estimación de los costes de los cuidados informales asociados a enfermedades neurológicas de alta prevalencia en España

Pharmacoeconomics - Spanish Research Articles

Volumn 4, Issue 3, 2007, Pages 83-96

  Oliva, Juan ^a,b,c   Osuna, Rubén ^d   Jorgensen, Natalia ^c  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b FEDEA ^*

^c UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^d UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SPAIN;

EID: 45249115465     PISSN: 1695405X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03320929     Document Type: Article

References (57)

1. Wimo A. Time spent on informal and formal care giving for persons with dementia in Sweden. Health Policy 2002;61:255-68.
2. McDaid D. Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges. International Journal of Geriatric Psychiatry 2001;16:400-405.
3. Low JT, Payne S, Roderick P. The impact of stroke on informal carers: a literature review. Soc Sci Med. 1999;49:711-25.
4. López-Bastida J, Perestelo L , Serrano P, Oliva-Moreno J. Socioeconomic costs and quality of life of people with Alzheimer disease in Canary Island. Neurology 2006;67:2186-2191.
5. Durán MA. Los costes invisibles de la enfermedad. Fundación BBVA 2002. Madrid.
6. Patel A and Knapp M. Costs of mental illness in England. Mental Health Research Review 1998;5:4-10.
7. The economic and social costs of mental illness. The Sainsbury Centre for Mental Health, London. 2003.
8. Evers S, Struijs J, Ament A, Genugten M van, Jager J, Bos G van den. International comparison of stroke cost studies. Stroke 2004;35:1209-15.
9. Jönsson L, Berr C. Cost of dementia in Europe. Eur J Neurol 2005;12:50-3.
10. Kobelt G, Lindgren P, Parkin D, Francis D, Johnson M, Bates D, Jonsson B. Costs and quality of life in multiple sclerosis. A cross-sectional observational study in the United Kingdom. EFI Research Report 398. Stockholm: Stockholm School of Economics; 2000.
11. Kobelt G, Lindgren P, Smala A, Bitsch A, Haupts M, Kolmel H, Konig N, Rieckmann P, Zettl U. the German Cost of MS Study Group. Costs and quality of life in multiple sclerosis. A cross-sectional study in Germany. HEPAC 2001;2:60-8.
12. Kobelt G, Pugliatti M. Cost of multiple sclerosis in Europe. Eur J Neurol 2005;12:63-7.
13. Lindgren P. Economic evidence in Parkinson's disease: A review. Eur J Health Econ 2004;5:S63-S66.
14. Lindgren P, Campenhausen S von, Spottke E, Siebert U, Dodel R. Cost of Parkinson's disease in Europe. Eur J Neurol 2005;12:68-73.
15. Moise P, Schwarzinger M, Um MY. Dementia care in 9 OECD countries: A comparative analysis [working paper]. France: OECD; 2004.
16. Posnett J and Jan S, "Indirect Cost in Economic Evaluation: The Opportunity Cost of Unpaid Inputs", Health Economics 1996,5:13-23.
17. Van den Berg B, Brouwer W, Koopmanschap M. Economic valuation of informal care: An overview of methods and applications. Eur J Health Econ 2004;5:36-45.
18. Van den Berg B. Informal care: An economic approach. Rotterdam: University of Rotterdam; Thesis Erasmus 2005
19. Ernst RL. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-4.
20. Hux M, O'Brien B, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation between severity of Alzheimer's disease and costs of caring. Can Med Assoc J 1998;159:457.
21. Leon J, Cheng CK, Neumann PJ. Alzheimer's disease care: costs and potential savings. Health Aff 1998;17:206-16.
22. Langa KM, Chernew ME, Kabeto MU, Herzog AR, Ofstedal MB, Willis RJ, Wallace RB, Mucha LM, Straus WL, Fendrick AM. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001;16:770-8.
23. Boada M, Peña-Casanova J, Bermejo F, et al. Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain. Med Clin 1999;113:690-695.
24. Artaso B, Martín M, Cabasés JM. El coste del paciente anciano con patología psicogeriátrica en la comunidad. Actas Esp Psiquiatr 2002;30:135-41.
25. López-Pousa S, Garre-Olmo J, Turon-Estrada A, Hernández F, Expósito I, Lozano-Gallego M et al. Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional. Med Clin 2004;122:767-72.
26. Otal M, Antoñanzas F, Ara JR. Análisis sociosanitario y cálculo de costes de la enfermedad de Alzheimer. Estudios en La Rioja. En: Martínez JM, Pacual LF. Alzheimer 2003: ¿Qué hay de nuevo?. Madrid: Aula Médica Ediciones; 2003:305-22.
27. Sicras A, Rejas J, Arco S, Flores E, Ortega G, Esparcia A et al. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting. Dement Geriatr Cogn Disord 2005;19:305-15.
28. Kobelt G. Economic evidence in multiple sclerosis: A review. Eur J Health Econ 2004;5:S54-62.
29. Amato MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A, Trojano M, Mu S. The costs of multiple sclerosis: A cross-sectional, multicenter cost-of-illness study in Italy. J Neurol 2002;249:152-63.
30. Henriksson F, Fredrikson S, Masterman T, Jonsson B (a). Costs, quality of life and disease severity in multiple sclerosis. A cross-sectional study in Sweden. Eur J Neurol 2001;8:27-35.
31. Whetten-Goldstein K, Sloan F, Goldstein L, Kulas E. A comprehensive assessment of the cost of multiple sclerosis in the United States. Multiple Sclerosis 1998;4:419-25.
32. Claesson L, Linden T, Skoog I, Blomstrand C. Cognitive impairment after stroke - Impact on activities of daily living and costs of care for elderly people. The Goteborg 70+ Stroke Study. Cerebrovasc 2005;19:102-9.
33. Evers A, Leichsenring K. Asistencia informal remunerada: Una cuestión de creciente importancia. Rev Gerontol 1994;4:114-24.
34. Zethraeus N, Molin T, Henriksson P, Jonsson BV. Costs of coronary heart disease and stroke: The case of Sweden. J Intern Med 1999;246:151-9.
35. Claesson L, Gosman-Hedstrom G, Johannesson M, Fagerberg B, Blomstrand C. Resource utilization and costs of stroke unit care integrated in a care continuum. A 1-year controlled, prospective, randomized study in elderly patients: The Goteborg 70+ Stroke Study. Stroke 2000;31:2569-77.
36. Hickenbottom SL, Fendrick AM, Kutcher JS, Kabeto MU, Katz SJ, Langa KM. A national study of the quantity and cost of informal caregiving for the elderly with stroke. Neurology 2002;58:1754-9.
37. Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. Pharmacoeconomics 2003;21(Suppl 1):43-50.
38. Jorgensen N, Oliva J, López-Bastida J , Serrano P. Análisis de los costes sociales de los accidentes cerebrovasculares en la Comunidad Canaria. Mimeo, 2007.
39. Dodel RC, Singer M, Kohne-Volland R, Selzer R, Scholz W, Rathay B, Oertel WH. [Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs]. Nervenarzt 1997;68:978-84.
40. Findley L, Aujla M, Bain PG, Baker M, Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG, Peto V, Playfer JR. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. Mov Disord 2003;18:1139-45.
41. Hagell P, Nordling S, Reimer J, Grabowski M, Persson U. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov Disord 2002;17:1213-20.
42. Keranen T, Kaakkola S, Sotaniemi K, Laulumaa V, Haapaniemi T, Jolma T, Kola H, Ylikoski A, Satomaa O, Kovanen J. Taimela E, Haapaniemi H, Turunen H, Takala A. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 2003;9:163-8.
43. LePen C. Wait S. Moutard-Martin F. Dujardin M. Ziegler M. Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics 1999;16:59-69
44. Instituto Nacional de Estadística. Encuesta sobre Discapacidades, Deficiencias y Estado de Salud 1999. (www.ine.es)
45. Brower W, Rutten F, Koopmanschap M. Costing in economics evaluations. In M Drummond and A McGuire. Economic evaluation in health care. OHE. Oxford University Press, 2001.
46. Smith, K. y Wright, K. Informal care and economic appraisal: a discussion of possible methodological approaches. Health Economics 1994;3:137-148.
47. Encuesta de Estructura Salarial. Instituto Nacional de Estadística. 2002 (www.ine.es )
48. Encuesta de Apoyo Informal a Personas Mayores. IMSERSO. Año 2004
49. van den Berg, B. and Spauwen, P. 2006. Measurement of informal care: an empirical study into the valid measurement of time spent on informal caregiving, Health Economics, 15:447-460.
50. Neumann PJ, Kuntz KM, Leon J, et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care 1999;37:27-32.
51. Van Exel NJ, Koopmanschap MA, van den Berg B, Brouwer WB, van den Bos GA. Burden of informal caregiving for stroke patients. Identification of caregivers at risk of adverse health effects. Cerebrovasc Dis. 2005;19:11-7.
52. Hamalainen H, Smith R, Puukka P, Lind J, Kallio V, Kuttila K, Ronnemaa T. Social support and physical and psychological recovery one year after myocardial infarction or coronary artery bypass surgery. Scand J Public Health. 2000;28:62-70.
53. Proctor EK, Morrow-Howell N, Li H, Dore P. Adequacy of home care and hospital readmission for elderly congestive heart failure patients. Health Soc Work. 2000;25:87-96.
54. Boyd KJ, Murray SA, Kendall M, Worth A, Frederick Benton T, Clausen H. Living with advanced heart failure: a prospective, community based study of patients and their carers. Eur J Heart Fail. 2004;6:585-91.
55. Ministerio de Sanidad y Consumo (2004). Cuentas Satélite del Gasto Sanitario Público (1988-2002) y Gasto Territorializado (1995-2002). Ministerio de Sanidad y Consumo, Madrid.
56. Comas-Herrera, Adelina; Wittenberg, R.; Costa-i-Font, J: Gori, C.; di Maio, A.; Patxot, C.; Pickard, L.; Pozzi, A.; Rothgang. H. 'Future long-term care expenditure in Germany. Spain. Italy and the U.K.' Ageing and Society 2006;26:285-302.
57. Comas-Herrera, Adelina; Wittenberg, R.; (eds.). 'European Study of Long-Term Care Expenditure: Investigating the Sensitivity of Future Long-term Care Expenditure in Germany, Spain, Italy and the United Kingdom to Changes in Assumptions about Demography, Dependency, Informal Care, Formal Care and Unit Costs.' Report to the European Commission, Employment and Social Affairs DG. PSSRU discussion paper 1840. (2003)